Bank of New York Mellon’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.7M Buy
437,604
+24,188
+6% +$1.01M ﹤0.01% 1471
2026
Q1
$13.3M Sell
413,416
-13,110
-3% -$485K ﹤0.01% 1768
2025
Q4
$18M Sell
426,526
-22,807
-5% -$919K ﹤0.01% 1600
2025
Q3
$15.4M Buy
449,333
+211,000
+89% +$6.05M ﹤0.01% 1681
2025
Q2
$6.44M Sell
238,333
-9,891
-4% -$286K ﹤0.01% 2129
2025
Q1
$7.36M Buy
248,224
+4,772
+2% +$182K ﹤0.01% 2011
2024
Q4
$9.64M Buy
243,452
+20,906
+9% +$792K ﹤0.01% 1943
2024
Q3
$7.58M Sell
222,546
-59,264
-21% -$1.67M ﹤0.01% 2076
2024
Q2
$6.11M Buy
281,810
+31,613
+13% +$665K ﹤0.01% 2233
2024
Q1
$5.54M Sell
250,197
-41,352
-14% -$1.01M ﹤0.01% 2276
2023
Q4
$8.02M Sell
291,549
-5,298
-2% -$128K ﹤0.01% 2109
2023
Q3
$6.63M Buy
296,847
+39,440
+15% +$1.01M ﹤0.01% 2175
2023
Q2
$6.56M Buy
257,407
+4,178
+2% +$101K ﹤0.01% 2172
2023
Q1
$5.65M Sell
253,229
-2,224
-0.9% -$53.8K ﹤0.01% 2234
2022
Q4
$6.06M Buy
255,453
+619
+0.2% +$14.4K ﹤0.01% 2222
2022
Q3
$4.23M Buy
254,834
+22,393
+10% +$504K ﹤0.01% 2375
2022
Q2
$4.63M Sell
232,441
-104,002
-31% -$2.1M ﹤0.01% 2356
2022
Q1
$9.28M Sell
336,443
-12,056
-3% -$345K ﹤0.01% 2102
2021
Q4
$14.4M Sell
348,499
-3,055
-0.9% -$135K ﹤0.01% 1907
2021
Q3
$16.3M Buy
351,554
+1,743
+0.5% +$76.1K ﹤0.01% 1832
2021
Q2
$14M Sell
349,811
-490,088
-58% -$21M ﹤0.01% 1949
2021
Q1
$45.1M Buy
839,899
+71,623
+9% +$4.13M 0.01% 1179
2020
Q4
$37.6M Buy
768,276
+21,424
+3% +$993K 0.01% 1231
2020
Q3
$24.3M Buy
746,852
+61,012
+9% +$1.94M 0.01% 1349
2020
Q2
$17.8M Buy
685,840
+31,792
+5% +$792K ﹤0.01% 1515
2020
Q1
$15.9M Buy
654,048
+15,736
+2% +$396K 0.01% 1432
2019
Q4
$17.8M Sell
638,312
-17,248
-3% -$446K ﹤0.01% 1638
2019
Q3
$15.7M Buy
655,560
+368,403
+128% +$9.8M ﹤0.01% 1663
2019
Q2
$8.19M Buy
287,157
+135,902
+90% +$3.39M ﹤0.01% 2076
2019
Q1
$3.79M Sell
151,255
-11,780
-7% -$225K ﹤0.01% 2466
2018
Q4
$2.05M Buy
163,035
+71,525
+78% +$846K ﹤0.01% 2710
2018
Q3
$874K Buy
91,510
+20,815
+29% +$230K ﹤0.01% 3349
2018
Q2
$660K Sell
70,695
-3,666
-5% -$25.8K ﹤0.01% 3479
2018
Q1
$413K Buy
74,361
+4,207
+6% +$26K ﹤0.01% 3668
2017
Q4
$459K Sell
70,154
-2,305
-3% -$17.1K ﹤0.01% 3649
2017
Q3
$635K Sell
72,459
-157
-0.2% -$1.28K ﹤0.01% 3465
2017
Q2
$605K Buy
72,616
+11,304
+18% +$92.2K ﹤0.01% 3513
2017
Q1
$563K Buy
61,312
+1,795
+3% +$14.7K ﹤0.01% 3510
2016
Q4
$461K Buy
59,517
+16,140
+37% +$121K ﹤0.01% 3622
2016
Q3
$330K Sell
43,377
-2,429
-5% -$13.7K ﹤0.01% 3730
2016
Q2
$231K Buy
45,806
+3,955
+9% +$21.2K ﹤0.01% 3847
2016
Q1
$226K Hold
41,851
﹤0.01% 3747
2015
Q4
$301K Hold
41,851
﹤0.01% 3725
2015
Q3
$197K Sell
41,851
-5,112
-11% -$48.7K ﹤0.01% 3912
2015
Q2
$523K Buy
46,963
+21,781
+86% +$214K ﹤0.01% 3622
2015
Q1
$183K Sell
25,182
-40
-0.2% -$328 ﹤0.01% 3914
2014
Q4
$244K Sell
25,222
-368
-1% -$2.87K ﹤0.01% 3842
2014
Q3
$249K Buy
25,590
+267
+1% +$3.5K ﹤0.01% 3834
2014
Q2
$434K Buy
25,323
+9,397
+59% +$135K ﹤0.01% 3646
2014
Q1
$273K Buy
+15,926
New +$254K ﹤0.01% 3763

Other funds holding VCYT

Bank of New York Mellon's VCYT Position: Q2 2026 in Review

Bank of New York Mellon increased its Veracyte (VCYT) stake by 5.9% in Q2 2026, buying an estimated $1.01M and bringing the position to 437,604 shares worth $25.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1471.

Bank of New York Mellon first reported a position in VCYT in Q1 2014 and has held it in 50 quarters since. The position peaked at $45.1M in Q1 2021. 159 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Bank of New York Mellon held 437,604 shares of Veracyte worth $25.7M as of Q2 2026.
  • Bank of New York Mellon bought 24,188 Veracyte shares in Q2 2026, an estimated $1.01M.
  • Veracyte made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1471 holding.
  • Bank of New York Mellon first reported a position in Veracyte in Q1 2014 and has held it in 50 quarters since.
  • Bank of New York Mellon's Veracyte position peaked at $45.1M in Q1 2021.
  • 159 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.